医学
糖尿病
肠促胰岛素
内科学
2型糖尿病
重症监护医学
心脏病学
生物信息学
胰高血糖素样肽-1
心力衰竭
风险因素
糖尿病肾病
内分泌学
梅德林
低血糖
心肾综合症
作者
José Pablo Miramontes-González,Álvaro Rodrigo-Alaíz,Miriam Gabella-Martín,David González-Calle,Juana Carretero-Gómez,Luís Corral-Gudino
标识
DOI：10.1007/s13300-025-01829-1
摘要
Incretin-based therapy has shifted care from glucose-centric targets to cardiorenal risk reduction. GLP-1RA are guideline-endorsed for patients with T2DM and high CV/renal risk irrespective of HbA1c; dual agonists and oral small-molecule agents may broaden indications pending definitive outcome evidence.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Copyright
Kao
无极微光
潇洒的惋清
Nole
学术文献互助
cdercder
魔法屎尿屁
Zephyrite
务实狗
arniu2008
蓝天
OK
GingerF
XL
行走的荷尔蒙
sagitar
Nexus
雪满头
核桃
皖公网安备34019202002308
